CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,449,831 | -7.4% | 6,535,674 | +32.5% | 9.21% | -26.2% |
| Q4 2022 | $29,653,941 | -10.1% | 4,934,100 | -13.0% | 12.48% | -15.9% |
| Q3 2022 | $32,996,000 | +50.1% | 5,669,388 | +54.0% | 14.83% | +45.1% |
| Q2 2022 | $21,977,000 | +0.5% | 3,681,195 | -21.4% | 10.22% | +12.7% |
| Q1 2022 | $21,876,000 | +0.2% | 4,684,404 | -46.8% | 9.07% | -9.4% |
| Q4 2021 | $21,825,000 | -7.1% | 8,800,358 | +10.5% | 10.02% | -6.3% |
| Q3 2021 | $23,495,000 | +23.1% | 7,964,329 | +4.3% | 10.69% | +7.1% |
| Q2 2021 | $19,081,000 | +99.1% | 7,632,530 | +131.8% | 9.98% | +92.7% |
| Q1 2021 | $9,584,000 | +44.9% | 3,293,419 | +60.3% | 5.18% | +2.3% |
| Q4 2020 | $6,614,000 | -18.4% | 2,054,000 | -45.5% | 5.06% | -39.9% |
| Q3 2020 | $8,102,000 | +71.7% | 3,768,597 | -7.4% | 8.43% | -7.8% |
| Q2 2020 | $4,719,000 | -20.2% | 4,068,191 | -36.7% | 9.14% | +46.1% |
| Q1 2020 | $5,916,000 | -0.3% | 6,430,637 | +71.3% | 6.26% | +51.3% |
| Q4 2019 | $5,933,000 | +91.0% | 3,755,000 | +1.2% | 4.14% | +37.1% |
| Q3 2019 | $3,107,000 | -7.4% | 3,711,999 | -4.9% | 3.02% | +30.6% |
| Q2 2019 | $3,355,000 | -13.6% | 3,904,400 | -2.4% | 2.31% | +3.5% |
| Q1 2019 | $3,881,000 | -7.6% | 4,000,000 | -30.2% | 2.23% | -39.5% |
| Q4 2018 | $4,201,000 | -63.3% | 5,726,579 | +8.0% | 3.69% | -44.9% |
| Q3 2018 | $11,452,000 | -43.2% | 5,302,063 | +30.9% | 6.70% | -45.4% |
| Q2 2018 | $20,166,000 | +0.6% | 4,049,298 | -21.2% | 12.25% | +14.0% |
| Q1 2018 | $20,053,000 | +307.8% | 5,141,746 | +180.2% | 10.74% | +264.6% |
| Q4 2017 | $4,917,000 | +55.2% | 1,834,838 | +84.8% | 2.95% | +57.8% |
| Q3 2017 | $3,168,000 | -58.1% | 993,000 | -56.5% | 1.87% | -54.3% |
| Q2 2017 | $7,561,000 | – | 2,284,381 | – | 4.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |